When can my child go to school? A COVID-19 primer

Two of the Boston area’s top experts (and parents) weigh in.

Trump May Be Immune to the Coronavirus. But for How Long?

A unique treatment course may have blunted his body’s production of antibodies, scientists warn.

Schools (and Children) Need a Fresh Air Fix

Classrooms have needed better ventilation for years. It took a pandemic to get us to pay attention.

Johnson & Johnson Pauses Coronavirus Vaccine Trial Over Unexplained Illness

Johnson & Johnson has paused its COVID-19 vaccine trial after an “unexplained illness” of one the participants. The vaccine is currently in development as part of a partnership between Johnson & Johnson and a team led by Dan Barouch, MD, PhD (Center for Virology and Vaccine Research, BIDMC).

Covid-19 Reinfection Documented in Nevada Adds to Questions on Virus Immunity

Case of man reinfected with the coronavirus, reported in a Lancet medical journal, joins a number of Covid-19 second-cases world-wide

COVID-19 Deadlier for Men than Women, HMS Study Shows

A recently released review article from researchers at BIDMC showed that COVID-19 results in higher case numbers and mortality rates in men than women.

Donald Trump’s COVID-19 treatment is similar to the average American hospitalized with coronavirus. Only faster.

President Trump received mostly the same treatment as anyone would get for COVID-19, except for one experimental drug and the speed of his care.

The FDA Is Slowing Down COVID-19 Vaccine Approval. That Could Be Good for Public Health

Dan Barouch, MD, PhD (Center for Virology and Vaccine Research, BIDMC) discusses the importance of ensuring the public that a COVID-19 vaccine is safe and effective in order to end the pandemic.

These are the experts on Gov. Baker’s Covid-19 vaccine distribution group

Sharon Wright, MD (Infectious Disease, BIDMC) has been named to a 17-member panel which will advise Governor Charlie Baker on a COVID-19 vaccine and its distribution.